FrancophonIA/ELRC3.0 huggingface dataset:
English: Exelon might interfere with anticholinergic medicines (medicines used to relieve stomach cramps or spasms, to treat Parkinson's disease or to prevent travel sickness).
Croatian: Exelon može utjecati na antikolinergičke lijekove (lijekove koji se koriste za ublažavanje grčeva ili spazama u želucu, za liječenje Parkinsonove bolesti ili za sprečavanje mučnine na putovanju).
English: Patients and caregivers should be instructed on important administration instructions:
Croatian: Bolesnici i njegovatelji trebaju dobiti važne upute o primjeni:
English: Overdose with Exelon transdermal patch resulting from misuse/dosing errors (application of multiple patches at a time) has been reported in the post-marketing setting and rarely in clinical trials.
Croatian: Predoziranje Exelon transdermalnim flasterom koje je posljedica neodgovarajuće primjene/pogreške u doziranju (primjene više flastera istodobno) zabilježeno je nakon stavljanja lijeka u promet te rijetko u kliničkim ispitivanjima.
English: Exelon capsules 12 mg/day N = 256
Croatian: Exelon kapsule 12 mg/dan N=256
English: • Treatment usually starts with Exelon 4.6 mg/24 h.
Croatian: • Liječenje obično počinje Exelonom 4,6 mg/24 h.
English: The following additional adverse reaction has been observed in a study of patients with dementia associated with Parkinson's disease treated with Exelon transdermal patches: agitation (common).
Croatian: Sljedeća dodatna nuspojava zabilježena je u ispitivanju na bolesnicima s demencijom povezanom s Parkinsonovom bolešću, koji su liječeni Exelon transdermalnim flasterima: agitiranost (često).
English: The following adverse reactions, listed below in Table 1, have been accumulated in patients with Alzheimer's dementia treated with Exelon.
Croatian: Sljedeće nuspojave, navedene u Tablici 1, prikupljene su u bolesnika s Alzheimerovom demencijom liječenih Exelonom.
English: Table 2 shows the adverse reactions reported during clinical studies conducted in patients with dementia associated with Parkinson's disease treated with Exelon capsules.
Croatian: Tablica 2 pokazuje nuspojave zabilježene tijekom kliničkih ispitivanja provedenih u bolesnika s demencijom povezanom s Parkinsonovom bolešću, liječenih Exelon kapsulama.
English: What you need to know before you take Exelon
Croatian: Što morate znati prije nego počnete uzimati Exelon
English: The following adverse reactions have only been observed with Exelon capsules and oral solution and not in clinical studies with Exelon transdermal patches: malaise, confusion, sweating increased (common); duodenal ulcers, angina pectoris (rare); gastrointestinal haemorrhage (very rare); and some cases of severe vomiting were associated with oesophageal rupture (not known).
Croatian: Sljedeće su nuspojave uočene samo s Exelon kapsulama i oralnom otopinom, a ne u kliničkim ispitivanjima s Exelon transdermalnim flasterima: malaksalost, smetenost, pojačano znojenje (često); ulkus na dvanaesniku, angina pectoris (rijetko); gastrointestinalno krvarenje (vrlo rijetko); a neki slučajevi teškog povraćanja bili su povezani s rupturom jednjaka (nepoznato).
English: If you have to undergo surgery whilst using Exelon transdermal patches, tell your doctor that you are using them because they may exaggerate the effects of some muscle relaxants during anaesthesia.
Croatian: Ako se, tijekom primjene Exelon transdermalnih flastera morate podvrgnuti operaciji, obavijestite svog liječnika da ih koristite jer oni mogu tijekom anestezije pojačati učinke nekih mišićnih relaksansa.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Exelon in all subsets of the paediatric population in the treatment of Alzheimer's dementia (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove izuzela je obvezu podnošenja rezultata ispitivanja lijeka Exelon u svim podskupinama pedijatrijske populacije u liječenju Alzheimerove demencije (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: EXP Use Exelon oral solution within 1 month of opening the bottle.
Croatian: EXP Upotrijebiti Exelon oralnu otopinu u roku od mjesec dana od otvaranja boce.
English: • Take Exelon twice a day, in the morning and evening, with food.
Croatian: • Exelon morate uzimati dvaput na dan, jednom uz doručak i jednom uz večeru.
English: Poly(butylmethacrylate, methylmethacrylate) Acrylic copolymer
Croatian: Poli(butilmetakrilat, metillmetakrilat) Akrilni kopolimer
English: By blocking these enzymes, Exelon allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer's disease and dementia associated with Parkinson's disease.
Croatian: Blokiranjem tih enzima, Exelon omogućava povećavanje koncentracije acetilkolina u mozgu te tako pomaže u smanjivanju simptoma Alzheimerove bolesti i demencije povezane s Parkinsonovom bolešću.
English: As rivastigmine has a plasma half-life of about 3.4 hours and a duration of acetylcholinesterase inhibition of about 9 hours, it is recommended that in cases of asymptomatic overdose all Exelon transdermal patches should be removed immediately and no further transdermal patch should be applied for the next 24 hours.
Croatian: S obzirom na to da je poluvijek rivastigmina u plazmi oko 3,4 sata, a trajanje inhibicije acetilkolinesteraze oko 9 sati, preporučuje se da se u slučajevima asimptomatskog predoziranja svi Exelon transdermalni flaster moraju se odmah ukloniti i novi se transdermalni flaster ne smije primijeniti sljedeća 24 sata.
English: The European Medicines Agency has waived the obligation to submit the results of studies with Exelon in all subsets of the paediatric population in the treatment of Alzheimer's dementia and in the treatment of dementia in patients with idiopathic Parkinson's disease (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove izuzela je obvezu podnošenja rezultata ispitivanja lijeka Exelon u svim podskupinama pedijatrijske populacije u liječenju Alzheimerove demencije te u liječenju demencije u bolesnika s idiopatskom Parkinsonovom bolešću (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: Application site skin reactions (usually mild to moderate application site erythema), are the most frequent adverse reactions observed with the use of Exelon transdermal patch.
Croatian: Kožne reakcije na mjestu primjene (obično blagi do umjereni eritem na mjestu primjene), najučestalije su nuspojave uočene s primjenom Exelon transdermalnih flastera.
English: Exelon capsules 12 mg/day
Croatian: Exelon kapsule 12 mg/dan
English: The oral solution is packaged with an oral dosing syringe in a plastic tube container.
Croatian: Oralna otopina pakirana je s dozirnom štrcaljkom za usta u plastičnom cjevastom spremniku.
English: Exelon 9 mg/5 cm 2, 18 mg/10 cm and 27 mg/15 cm transdermal patches are individually packaged in child-resistant, heat-sealed sachets made of a paper/polyethyleneterephthalate/aluminum/polyacrylnitrile (PAN) multi-laminated material (paper/PET/alu/PAN) or in heat-sealed, child-resistant sachets made of multi-layer composite laminate consisting of paper/polyethylene terephthalate/polyethylene/aluminum/polyamide (paper/PET/PE/alu/PA).
Croatian: 6.5 Vrsta i sadržaj spremnika Exelon 9 mg/5 cm2, 18 mg/10 cm i 27 mg/15 cm transdermalni flasteri su pojedinačno pakirani u vrećice sa sigurnosnom zaštitom za djecu koje su zatvorene toplinom i izrađene od papir/polietilentereftalat/aluminij/poliakrilonitril (PAN) multilaminatnog materijala (papir/PET/alu/PAN) ili u vrećice sa sigurnosnom zaštitom za djecu koje su zatvorene toplinom i izrađene od papir/polietilentereftalat/polietilen/aluminij/poliamid multilaminatnog materijala (papir/PET/PE/alu/PA).
English: No specific interaction studies have been performed with Exelon transdermal patches.
Croatian: Nisu provedena specifična ispitivanja interakcija s Exelon transdermalnim flasterima.
English: • Tell your caregiver that you are taking Exelon.
Croatian: • Osobi koja brine o Vama recite da uzimate Exelon.
English: The outer layer is beige and labelled with the following: - “Exelon”, “4.6 mg/24 h” and “AMCX”, - “Exelon”, “9.5 mg/24 h” and “BHDI”, - “Exelon”, “13.3 mg/24 h” and “CNFU”.
Croatian: Vanjski je sloj bež boje i označen sljedećim oznakama: - „Exelon“, „4,6 mg/24 h“ i „AMCX“, - „Exelon“, „9,5 mg/24 h“ i „BHDI“, - „Exelon“, „13,3 mg/24 h“ i „CNFU“.
English: The following additional adverse reactions have been observed with Exelon transdermal patches: delirium, pyrexia, decreased appetite, urinary incontinence (common), psychomotor hyperactivity (uncommon), erythema, urticaria, vesicles, allergic dermatitis (not known).
Croatian: Kod primjene Exelon transdermalnog flastera zabilježene su sljedeće dodatne nuspojave: delirij, pireksija, smanjeni apetit, inkontinencija mokraće (često), psihomotorička hiperaktivnost (manje često), eritem, urtikarija, vezikule, alergijski dermatitis (nepoznato).
English: Switching from capsules or oral solution to transdermal patches Based on comparable exposure between oral and transdermal rivastigmine (see section 5.2), patients treated with Exelon capsules or oral solution can be switched to Exelon transdermal patches as follows:
Croatian: Na temelju usporedive izloženosti oralnom i transdermalnom rivastigminu (vidjeti dio 5.2), bolesnici liječeni Exelon kapsulama ili oralnom otopinom mogu prijeći na Exelon transdermalne flastere na sljedeći način:
English: Exelon might interfere with anticholinergic medicines some of which are medicines used to relieve stomach cramps or spasms (e.g. dicyclomine), to treat Parkinson's disease (e.g. amantadine) or to prevent motion sickness (e.g. diphenhydramine, scopolamine, or meclizine).
Croatian: Exelon može utjecati na antikolinergičke lijek (lijekovi koji se koriste za ublažavanje grčeva ili spazama u želucu (npr. diciklomin), za liječenje Parkinsonove bolesti (npr. amantadin) ili za sprječavanje putne mučnine (npr. difenhidramin, skopolamin ili meklizin).
English: Transdermal patches Rivastigmine in vivo release rates per 24 h
Croatian: In vivo stope oslobađanja rivastigmina u 24 h
English: Available in packs containing 7, 30 or 42 sachets and in multipacks containing 60, 84 or 90 sachets.
Croatian: Dostupno u pakiranjima koja sadrže 7, 30 ili 42 vrećice te u višestrukim pakiranjima koja sadrže 60, 84 ili 90 vrećica.
English: Patients with severe hepatic impairment have not been studied, however, Exelon capsules may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2).
Croatian: Nisu proučavani bolesnici s teškim oštećenjem jetre, međutim, Exelon kapsule mogu se primjenjivati u ovoj bolesničkoj populaciji pod uvjetom da se provodi pažljivo praćenje (vidjeti dijelove 4.4 i 5.2).
English: • Paediatric population: There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease.
Croatian: • Pedijatrijska populacija: Nema relevantne primjene Exelona u pedijatrijskoj populaciji u liječenju Alzheimerove bolesti.
English: Care must be taken when prescribing Exelon transdermal patches:
Croatian: Potreban je oprez kod propisivanja Exelon transdermalnih flastera:
English: ADCS-IADL scores: A positive difference in DLSM indicates greater improvement in Exelon 15 cm as compared to Exelon 10 cm
Croatian: Rezultati ADAS-cog-a: Negativna razlika u DLSM-u upućuje na veće poboljšanje kod Exelona 15 cm u usporedbi s Exelonom 10 cm Rezultati ADCS-IADL-a: Pozitivna razlika u DLSM-u upućuje na veće poboljšanje kod Exelona 15 cm u usporedbi s Exelonom 10 cm
English: However, these events did not occur at a higher frequency with Exelon 13.3 mg/24 h transdermal patches than with placebo.
Croatian: Međutim, ti se događaji nisu javljali učestalije s Exelon transdermalnim flasterima od 13,3 mg/24 h nego s placebom.
English: Exelon 4.6 mg/24 h transdermal patches and Exelon 9.5 mg/24 h transdermal patches are available in packs containing 7, 30 or 42 sachets and in multipacks containing 60, 84 or 90 sachets.
Croatian: Exelon 4,6 mg/24 h transdermalni flasteri i Exelon 9,5 mg/24 h transdermalni flasteri dostupni su u pakiranjima koja sadrže 7, 30 ili 42 vrećice te u višestrukim pakiranjima koja sadrže 60, 84 ili 90 vrećica.
English: • Only wear one Exelon patch at a time and replace the patch with a new one after 24 hours.
Croatian: • Smije se primijeniti samo jedan Exelon flaster koji je potrebno zamijeniti novim flasterom nakon 24 sata.
English: Exelon oral solution should be used within 1 month of opening the bottle.
Croatian: Exelon oralna otopina treba se primijeniti unutar mjesec dana od prvog otvaranja bočice.
English: Patients with severe hepatic impairment have not been studied, however, Exelon oral solution may be used in this patient population provided close monitoring is exercised (see sections 4.4 and 5.2).
Croatian: Nisu proučavani bolesnici s teškim oštećenjem jetre, međutim, Exelon oralna otopina može se primjenjivati u ovoj bolesničkoj populaciji pod uvjetom da se provodi pažljivo praćenje (vidjeti dijelove 4.4 i 5.2).
English: Exelon 13.3 mg/24 h transdermal patches are available in packs containing 7 or 30 sachets and in multipacks containing 60 or 90 sachets.
Croatian: Exelon 13,3 mg/24 h transdermalni flasteri su dostupni u pakiranjima koja sadrže 7 ili 30 vrećica te u višestrukim pakiranjima koja sadrže 60 ili 90 vrećica.
English: Other side effects seen with Exelon capsules or oral solution and which may occur with the patch:
Croatian: Ostale nuspojave zabilježene uz primjenu Exelon kapsula ili oralne otopine, a koje se mogu pojaviti s flasterima:
English: 7 transdermal patches 30 transdermal patches 42 transdermal patches
Croatian: 7 transdermalnih flastera 30 transdermalnih flastera 42 transdermalna flastera
English: Hepatitis Skin and subcutaneous tissue disorders Common
Croatian: Poremećaji kože i potkožnog tkiva Često
English: What Exelon contains - The active substance is rivastigmine hydrogen tartrate.
Croatian: Što Exelon sadrži - Djelatna tvar je rivastigminhidrogentartarat.
English: The efficacy of Exelon transdermal patches in patients with Alzheimer's dementia has been demonstrated in a 24-week double-blind, placebo-controlled core study and its open-label extension phase and in a 48-week double-blind comparator study.
Croatian: Djelotvornost Exelon transdermalnih flastera u bolesnika s Alzheimerovom demencijom dokazana je u 24-tjednom dvostruko slijepom, placebom kontroliranom osnovnom ispitivanju i u njegovom otvorenom produžetku te u 48-tjednom dvostruko slijepom ispitivanju s komparatorom.
English: Exelon Patch should not be given at the same time as metoclopramide (a medicine used to relieve or prevent nausea and vomiting).
Croatian: Exelon flaster se ne smije davati istodobno s metoklopramidom (lijekom koji se koristi za ublažavanje ili sprječavanje mučnine i povraćanja).
English: What Exelon looks like and contents of the pack - Exelon 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with red imprint “EXELON 1,5 mg” on the body.
Croatian: Kako Exelon izgleda i sadržaj pakiranja - Exelon 1,5 mg tvrde kapsule, sadrže bjelkasti do blago žuti prašak, imaju žutu kapicu i žuto tijelo, s crvenom oznakom „EXELON 1,5 mg“ na tijelu kapsule.
English: Exelon transdermal patches 9.5 mg/24 h N = 251
Croatian: Exelon Transdermalni flasteri 9,5 mg/24 h N=251
English: Exelon 1.5 mg hard capsules Exelon 3.0 mg hard capsules Exelon 4.5 mg hard capsules Exelon 6.0 mg hard capsules
Croatian: Exelon 1,5 mg tvrde kapsule Exelon 3,0 mg tvrde kapsule Exelon 4,5 mg tvrde kapsule Exelon 6,0 mg tvrde kapsule
English: Exelon should not be given at the same time as metoclopramide (a medicine used to relieve or prevent nausea and vomiting).
Croatian: Exelon se ne smije davati istodobno s metoklopramidom (lijekom koji se koristi za ublažavanje ili sprječavanje mučnine i povraćanja).
English: The outside of the backing layer is beige and labelled with “Exelon”, “4.6 mg/24 h” and “AMCX”.
Croatian: Vanjski dio potpornog sloja je bež boje s oznakama „Exelon“, „4.6 mg/24 h“ i „AMCX“.
English: Caution when Exelon is taken together with beta-blockers (medicines such as atenolol used to treat hypertension, angina and other heart conditions).
Croatian: Potreban je oprez kod uzimanja Exelona zajedno s beta blokatorima (lijekovima kao što je atenolol koji se koristi za liječenje hipertenzije, angine i drugih srčanih stanja).
English: You should not breast-feed during treatment with Exelon transdermal patches.
Croatian: Ne smijete dojiti tijekom liječenja Exelon transdermalnim flasterima.
English: What Exelon looks like and contents of the pack Exelon oral solution is supplied as 50 ml or 120 ml of a clear, yellow solution (2.0 mg/ml base) in an amber glass bottle with a child-resistant cap, foam liner, dip tube and self aligning plug.
Croatian: Exelon oralna otopina isporučuje se kao 50 ml ili 120 ml bistre, žute otopine (2,0 mg/ml baze) u smeđoj staklenoj boci sa sigurnosnim zatvaračem za djecu, pjenastom oblogom, umetnutom cjevčicom i čepom utisnutim u grlo boce.
English: Exelon 1.5 mg hard capsules Exelon 3.0 mg hard capsules Exelon 4.5 mg hard capsules Exelon 6.0 mg hard capsules rivastigmine
Croatian: Exelon 1,5 mg tvrde kapsule Exelon 3,0 mg tvrde kapsule Exelon 4,5 mg tvrde kapsule Exelon 6,0 mg tvrde kapsule rivastigmin
English: If you are pregnant, the benefits of using Exelon must be assessed against the possible effects on your unborn child. Exelon should not be used during pregnancy unless clearly necessary.
Croatian: Ako ste trudni, potrebno je ocijeniti koristi od uporabe Exelon transdermalnih flastera u usporedbi s mogućim učincima na Vaše nerođeno dijete.
English: Each Exelon 1.5 mg capsule contains 1.5 mg of rivastigmine.
Croatian: Svaka Exelon 1,5 mg kapsula sadrži 1,5 mg rivastigmina.
English: Exelon 13.3 mg/24 h transdermal patches: Each patch releasing 13.3 mg of rivastigmine per 24 hours is 15 cm and contains 27 mg of rivastigmine.
Croatian: Exelon 13,3 mg/24 h transdermalni flasteri: Svaki flaster koji oslobađa 13,3 mg rivastigmina tijekom 24 sata ima površinu 15 cm i sadrži 27 mg rivastigmina.
English: There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease.
Croatian: Nema relevantne primjene Exelona u pedijatrijskoj populaciji u liječenju Alzheimerove bolesti.
English: Polyester film, fluoropolymer-coated
Croatian: Poliesterski film, obložen fluoropolimerom 6.2 Inkompatibilnosti
English: Each Exelon 6.0 mg capsule contains 6.0 mg of rivastigmine.
Croatian: Svaka Exelon 6,0 mg kapsula sadrži 6,0 mg rivastigmina.
English: You should not breast-feed during treatment with Exelon.
Croatian: Ne smijete dojiti tijekom liječenja Exelonom.
English: How to take Exelon
Croatian: Kako uzimati Exelon
English: The outside of the backing layer is beige and labelled with “Exelon”, “13.3 mg/24 h” and “CNFU”.
Croatian: Vanjski dio potpornog sloja je bež boje s oznakama „Exelon“, „13.3 mg/24 h“ i „CNFU“.
English: Back
Croatian: Stražnja strana
English: Each Exelon 3.0 mg capsule contains 3.0 mg of rivastigmine.
Croatian: Svaka Exelon 3,0 mg kapsula sadrži 3,0 mg rivastigmina.
English: - Exelon 4.6 mg/24 h transdermal patches: Each patch releasing 4.6 mg of rivastigmine per 24 hours is 5 cm and contains 9 mg of rivastigmine.
Croatian: Exelon 4,6 mg/24 h transdermalni flasteri: Svaki flaster koji oslobađa 4,6 mg rivastigmina tijekom 24 sata ima površinu 5 cm i sadrži 9 mg rivastigmina.
English: • Swallow your medicine straight from the syringe.
Croatian: • Progutajte Exelon oralnu otopinu izravno iz štrcaljke.
English: No study was conducted with Exelon transdermal patches in subjects with hepatic impairment.
Croatian: Nije provedeno nikakvo ispitivnaje s Exelon transdermalnim flasterima u ispitanika s oštećenjem jetre.
English: 1 transdermal patch of 15 cm contains 27 mg rivastigmine and delivers 13.3 mg/24 h.
Croatian: 1 transdermalni flaster površine 15 cm sadrži 27 mg rivastigmina i oslobađa 13,3 mg/24 h.
English: - Exelon 9.5 mg/24 h transdermal patches: Each patch releasing 9.5 mg of rivastigmine per 24 hours is 10 cm and contains 18 mg of rivastigmine.
Croatian: Exelon 9,5 mg/24 h transdermalni flasteri: Svaki flaster koji oslobađa 9,5 mg rivastigmina tijekom 24 sata ima površinu 10 cm i sadrži 18 mg rivastigmina.
English: Each Exelon 4.5 mg capsule contains 4.5 mg of rivastigmine.
Croatian: Svaka Exelon 4,5 mg kapsula sadrži 4,5 mg rivastigmina.
English: The outside of the backing layer is beige and labelled with “Exelon”, “9.5 mg/24 h” and “BHDI”.
Croatian: Vanjski dio potpornog sloja je bež boje s oznakama „Exelon“, „9.5 mg/24 h“ i „BHDI“.
English: Exelon 2 mg/ml oral solution
Croatian: Exelon 2 mg/ml oralna otopina
English: Exelon 4.6 mg/24 h transdermal patch Exelon 9.5 mg/24 h transdermal patch Exelon 13.3 mg/24 h transdermal patch
Croatian: Exelon 4,6 mg/24 h transdermalni flaster Exelon 9,5 mg/24 h transdermalni flaster Exelon 13,3 mg/24 h transdermalni flaster
English: Exelon 4.6 mg/24 h transdermal patch Exelon 9.5 mg/24 h transdermal patch Exelon 13.3 mg/24 h transdermal patch rivastigmine
Croatian: Exelon 4,6 mg/24 h transdermalni flaster Exelon 9,5 mg/24 h transdermalni flaster Exelon 13,3 mg/24 h transdermalni flaster rivastigmin
English: Front
Croatian: Prednja strana
English: How to remove your Exelon transdermal patch
Croatian: Kako skinuti Exelon transdermalni flaster
English: Exelon transdermal patches 9.5 mg/24 h
Croatian: Exelon transdermalni flasteri 9,5 mg/24 h
English: - Exelon 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “EXELON 4,5 mg” on the body.
Croatian: - Exelon 4,5 mg tvrde kapsule, sadrže bjelkasti do blago žuti prašak, imaju crvenu kapicu i crveno tijelo, s bijelom oznakom „EXELON 4,5 mg“ na tijelu kapsule.
English: What Exelon contains - The active substance is rivastigmine.
Croatian: Sadržaj pakiranja i druge informacije Što Exelon sadrži - Djelatna tvar je rivastigmin.
English: How to apply your Exelon transdermal patch
Croatian: Kako staviti Exelon transdermalni flaster
English: • Use Exelon oral solution within 1 month of opening the bottle.
Croatian: • Exelon oralnu otopinu treba primijeniti unutar mjesec dana od prvog otvaranja bočice.
English: No study was conducted with Exelon transdermal patches in subjects with renal impairment.
Croatian: Nije provedeno nikakvo ispitivanje s Exelon transdermalnim flasterima u ispitanika s oštećenjem bubrega.
English: EU/1/98/066/023-026 EU/1/98/066/033-034 EU/1/98/066/039-042 EU/1/98/066/049-050
Croatian: EU/1/98/066/023-026 EU/1/98/066/033-034 EU/1/98/066/039-042
English: Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “EXELON 1,5 mg” on body.
Croatian: Bjelkasti do blago žuti prašak u kapsuli sa žutom kapicom i žutim tijelom, s crvenom oznakom „EXELON 1,5 mg“ na tijelu kapsule.
English: Children and adolescents There is no relevant use of Exelon in the paediatric population in the treatment of Alzheimer's disease.
Croatian: Pedijatrijska populacija Nema relevantne primjene Exelona u pedijatrijskoj populaciji u liječenju Alzheimerove bolesti.
English: Exelon 1.5 mg hard capsules
Croatian: Exelon 1,5 mg tvrde kapsule
English: How to store Exelon
Croatian: Kako čuvati Exelon
English: Exelon 3.0 mg hard capsules
Croatian: Exelon 3,0 mg tvrde kapsule
English: Exelon 1.5 mg hard capsules rivastigmine
Croatian: Exelon 1,5 mg tvrde kapsule rivastigmin
English: Where to apply your Exelon transdermal patch
Croatian: Gdje treba postaviti Exelon transdermalni flaster
English: - Exelon 3.0 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “EXELON 3 mg” on the body.
Croatian: - Exelon 3,0 mg tvrde kapsule, sadrže bjelkasti do blago žuti prašak, imaju narančastu kapicu i narančasto tijelo, s crvenom oznakom „EXELON 3 mg“ na tijelu kapsule.
English: Off-white to slightly yellow powder in a capsule with red cap and red body, with white imprint “EXELON 4,5 mg” on body.
Croatian: Bjelkasti do blago žuti prašak u kapsuli s crvenom kapicom i crvenim tijelom, s bijelom oznakom „EXELON 4,5 mg“ na tijelu kapsule.